Premium
Prolactin‐Secreting pituitary tumors
Author(s) -
Antunes J. Lobo,
Housepian Edgar M.,
Frantz Andrew G.,
Holub Donald A.,
Hui Robert M.,
Carmel Peter W.,
Quest Donald O.
Publication year - 1977
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410020210
Subject(s) - prolactin , galactorrhea , medicine , pituitary tumors , prolactinoma , prolactin cell , pituitary adenoma , adenoma , radiation therapy , secretion , endocrinology , pituitary neoplasm , pituitary gland , hormone
Prolactin secretion was evaluated in 69 patients with pituitary tumors. Among the 47 who were seen prior to treatment, hyperprolactinemia was present in 37 (79%). Excluding patients with galactorrhea, hyperprolactinemia was present in 19 (70%) of those seen before treatment. There was little correlation between tumor size and level of serum prolactin. Both transspheoidal surgery and radiotherapy greatly reduced the hyperprolactinemia, but a more rapid decrease was achieved with microsurgical removal of the secreting adenoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom